[Birth control pills, surgery and casting leads to high risk of venous thrombosis in women. Better prophylaxis is needed for surgical procedures, as shown in case-control study].
Centrum för läkemedelsepidemiologi, institutionen för medicin, Karolinska institutet, Stockholm. helle.kieler@ki.se
Helle
H
Kieler
Läkemedelsverket, Uppsala.
Ingemar
I
Persson
Centrum för läkemedelsepidemiologi, institutionen fär medicin, Karolinska institutet, Stockholm.
Anders
A
Sundström
Läkemedelsverket, Uppsala.
Karin
K
Hedenmalm
Centrum för hematologi, Karolinska universitetssjukhuset, Stockholm.
Jacob
J
Odeberg
Centrum för läkemedelsepidemiologi, Karolinska institutet, Stockholm.
Annica
A
Bergendal
D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use; D016022:Case-Control Studies; D002370:Casts, Surgical / Q000009:adverse effects*; D003277:Contraceptives, Oral, Combined / Q000009:adverse effects*; D003278:Contraceptives, Oral, Hormonal / Q000009:adverse effects*; D005165:Factor V / Q000235:genetics; D005260:Female; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D007103:Immobilization / Q000009:adverse effects; D008875:Middle Aged; D009765:Obesity / Q000150:complications; D011516:Prothrombin / Q000235:genetics; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects; D013514:Surgical Procedures, Operative / Q000009:adverse effects*; D011795:Surveys and Questionnaires; D054556:Venous Thromboembolism / Q000188:drug therapy / Q000209:etiology* / Q000235:genetics / Q000517:prevention & control
D000925:Anticoagulants; D003277:Contraceptives, Oral, Combined; D003278:Contraceptives, Oral, Hormonal; D006495:Heparin, Low-Molecular-Weight; C095381:factor V Leiden; D005165:Factor V; D011516:Prothrombin